First ‘cell rejuvenation’ therapy in humans: Can ageing finally be treated?
The innovative cell rejuvenation therapy, known as ER-100, is set to enter human trials, focused on enhancing the functionality of aging cells rather than attempting
The innovative cell rejuvenation therapy, known as ER-100, is set to enter human trials, focused on enhancing the functionality of aging cells rather than attempting to reverse the aging process. This revolutionary approach shows promise in potentially decelerating age-related decline and addressing conditions like Alzheimer's. However, medical professionals advise caution due to ongoing research into long-term safety and efficacy, indicating a shift in understanding aging as a fixed outcome.
The BriefWire